Concentration of Branched-Chain Amino Acids Is a Strong Risk Marker for Incident Hypertension

Jose L Flores-Guerrero1, Dion Groothof1, Margery A Connelly2

  • 1From the Department of Internal Medicine, Division of Nephrology (J.L.F.-G., D.G., S.J.L.B.), University of Groningen, University Medical Center Groningen, the Netherlands.

Insights

High levels of branched-chain amino acids (BCAAs) are linked to a greater risk of developing new-onset hypertension. This finding suggests BCAAs may play a role in hypertension development.

Area of Science:

  • Cardiovascular Science
  • Metabolic Health
  • Nutritional Biochemistry

Background:

  • Branched-chain amino acids (BCAAs) are implicated in cardiometabolic disease pathogenesis.
  • The specific association between BCAAs and incident hypertension is not well-established.

Purpose of the Study:

  • To investigate the relationship between plasma BCAA concentrations and the risk of developing new-onset hypertension.
  • To determine if BCAAs serve as a predictive marker for hypertension incidence.

Main Methods:

  • Prospective population-based cohort study (PREVEND) with 4169 participants.
  • Plasma BCAA levels measured via nuclear magnetic resonance spectroscopy.
  • Incident hypertension risk assessed using multivariable-adjusted Cox regression models over an 8.6-year median follow-up.

Main Results:

  • A significant association was observed between higher plasma BCAA concentrations and increased risk of incident hypertension.
  • Hazard ratio per one SD increase in BCAAs was 1.11 (95% CI, 1.02-1.20; P=0.01).
  • The association remained significant when BCAAs were analyzed categorically (HR for highest vs. lowest quartile: 1.36; P=0.003) and improved risk prediction models.

Conclusions:

  • Elevated plasma BCAA levels are prospectively associated with a higher risk of developing hypertension.
  • BCAAs may contribute to hypertension pathogenesis, independent of traditional risk factors.
  • Plasma BCAA concentration could be a valuable biomarker for hypertension risk assessment.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
511
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
433
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
698
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.6K
Assessment of blood pressure in brachial artery(one-step method)01:15

Assessment of blood pressure in brachial artery(one-step method)

This procedural guide systematically measures blood pressure using an oscillometric digital sphygmomanometer, emphasizing accuracy, patient safety, and comfort.
Prepare for the Procedure:
1.1K
Factors affecting Blood pressure01:28

Factors affecting Blood pressure

Several physiological and lifestyle factors influence blood pressure (BP). Understanding these factors is crucial as they are significant in patient education and blood pressure management.
Physiological Factors:
6.3K